For the Culture By The Culture. ISSN: 3064-9331.
4/20 has been hollowed out by branding, corporate silence, and a culture that forgot its own history. While the industry sells holiday merch, Singapore executed a man for cannabis. The movement that once fought for autonomy now treats the plant like a commodity. This piece examines the cost of that betrayal and the culture left behind.
Virginia legalized possession, but Governor Abigail Spanberger sabotaged the retail market. By delaying sales until 2027 and gutting equity provisions, the Commonwealth institutionalized a half-legal trap. Consumers now navigate a system that treats possession as a right but supply as a crime, fueling an unchecked illicit market while abandoning promised reform. Spanberger’s public safety rhetoric is clearly a mask for obstruction.
Ed Rosenthal recounts how the magazine was born not from psychedelic myth but from hard numbers. Rolling paper import data, underground press experience, and market logic revealed a massive hidden cannabis audience. His account challenges the romantic origin story and offers a rare firsthand look at the early mechanics behind one of cannabis culture’s most influential publications.
Ohio’s attempt to restrict intoxicating hemp sales is already facing legal resistance. A judge has blocked enforcement of key provisions, raising questions about whether the law protects consumers or reshapes the cannabis market. The case could set a precedent for how states regulate hemp derived THC products across the country.
Cannabis is often labeled addictive, but the science tells a more precise story. This piece breaks down cannabis use disorder, how it is defined, and why mild, moderate, and severe cases get flattened into one fear-driven narrative. The result is a distorted public understanding of risk that fuels policy, perception, and misinformation.
Australia’s medical cannabis system expanded rapidly through telehealth and high-volume prescribing. Now regulators are tightening oversight. The TGA and AHPRA are increasing scrutiny on prescribing practices, signaling a shift from rapid patient access toward stricter clinical control that could reshape how doctors prescribe and how patients obtain treatment.
